Cargando…

Neurological Involvement in COVID-19 Among Non-Hospitalized Adolescents and Young Adults

INTRODUCTION: Coronavirus disease 2019 (COVID-19) is prevalent among young people, and neurological involvement has been reported. We investigated neurological symptoms, cognitive test results, and biomarkers of brain injury, as well as associations between these variables in non-hospitalized adoles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Havdal, Lise Beier, Berven, Lise Lund, Selvakumar, Joel, Stiansen-Sonerud, Tonje, Leegaard, Truls Michael, Tjade, Trygve, Zetterberg, Henrik, Blennow, Kaj, Wyller, Vegard Bruun Bratholm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257204/ https://www.ncbi.nlm.nih.gov/pubmed/35812102 http://dx.doi.org/10.3389/fneur.2022.915712

Ejemplares similares

Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults
por: Lund Berven, Lise, et al.
Publicado: (2022)

Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild COVID-19
por: Sommen, Silke Lauren, et al.
Publicado: (2023)

Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults
por: Selvakumar, Joel, et al.
Publicado: (2023)

Autonomic cardiovascular control in older patients with acute infection and delirium: a pilot study of orthostatic stress responses
por: Neerland, Bjørn Erik, et al.
Publicado: (2019)

Are there subgroups of chronic fatigue syndrome? An exploratory cluster analysis of biological markers
por: Asprusten, Tarjei Tørre, et al.
Publicado: (2021)

Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease
por: Jeppsson, Anna, et al.
Publicado: (2022)

Clinical Phenotyping and Biomarkers in Spinal and Bulbar Muscular Atrophy
por: Millere, Elina, et al.
Publicado: (2021)

Examining four blood biomarkers for the detection of acute intracranial abnormalities following mild traumatic brain injury in older adults
por: Iverson, Grant L., et al.
Publicado: (2022)

One-Year Prospective Study of Plasma Biomarkers From CNS in Patients With Mild Traumatic Brain Injury
por: Clarke, Gerard Janez Brett, et al.
Publicado: (2021)

Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers
por: Neselius, Sanna, et al.
Publicado: (2014)

Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection With Associations to Chronic Low-Grade Inflammation and Fatigue
por: Fevang, Børre, et al.
Publicado: (2021)

Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults
por: Huebschmann, Nathan A., et al.
Publicado: (2020)

The burden of hospital-attended influenza in Norwegian children
por: Bøås, Håkon, et al.
Publicado: (2022)

Serum erythropoietin and outcome after ischaemic stroke: a prospective study
por: Åberg, N David, et al.
Publicado: (2016)

No differences in cardiovascular autonomic responses to mental stress in chronic fatigue syndrome adolescents as compared to healthy controls
por: Egge, Caroline, et al.
Publicado: (2010)

Viral lower respiratory tract infections—strict admission guidelines for young children can safely reduce admissions
por: Havdal, Lise Beier, et al.
Publicado: (2021)

Correction to: Viral lower respiratory tract infections—strict admission guidelines for young children can safely reduce admissions
por: Havdal, Lise Beier, et al.
Publicado: (2023)

Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study
por: Bromander, Sara, et al.
Publicado: (2012)

Cerebrospinal Fluid S100B and Alzheimer's Disease Biomarkers in Hip Fracture Patients with Delirium
por: Hov, Karen Roksund, et al.
Publicado: (2017)

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
por: Blennow, Kaj, et al.
Publicado: (2010)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
por: Blennow, Kaj, et al.
Publicado: (2015)

The Past and the Future of Alzheimer’s Disease Fluid Biomarkers(1)
por: Blennow, Kaj, et al.
Publicado: (2018)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
por: Zetterberg, Henrik, et al.
Publicado: (2021)

Reduced Sympathetic Response to Head-Up Tilt in Subjects with Mild Cognitive Impairment or Mild Alzheimer's Dementia
por: Mellingsæter, Marte Rognstad, et al.
Publicado: (2015)

Commentary: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
por: Karikari, Thomas K., et al.
Publicado: (2018)

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
por: Yilmaz, Aylin, et al.
Publicado: (2019)

Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre‐analytical conditions
por: Simrén, Joel, et al.
Publicado: (2021)

CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics
por: Jeppsson, Anna, et al.
Publicado: (2019)

Blood pressure variability and closed-loop baroreflex assessment in adolescent chronic fatigue syndrome during supine rest and orthostatic stress
por: Wyller, Vegard Bruun, et al.
Publicado: (2010)

Listeria monocytogenes infection associated with alemtuzumab – - a case for better preventive strategies
por: Holmøy, Trygve, et al.
Publicado: (2017)

Autonomic cardiovascular control changes in recent heart transplant recipients lead to physiological limitations in response to orthostatic challenge and isometric exercise
por: Nygaard, Sissel, et al.
Publicado: (2019)

Early Neurological Improvement Predicts Clinical Outcome After Thrombectomy for Distal Medium Vessel Occlusions
por: Wang, Maud, et al.
Publicado: (2022)

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
por: Mattsson, Niklas, et al.
Publicado: (2010)

Cerebrospinal Fluid Analysis Should Be Considered in Patients with Cognitive Problems
por: Zetterberg, Henrik, et al.
Publicado: (2010)

Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease
por: Andreasen, Niels, et al.
Publicado: (2010)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
por: Andreasson, Ulf, et al.
Publicado: (2016)

Plasma neurodegeneration biomarker concentrations associate with glymphatic and meningeal lymphatic measures in neurological disorders
por: Eide, Per Kristian, et al.
Publicado: (2023)

ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease – Study Protocol and Baseline Characteristics
por: Snellman, Anniina, et al.
Publicado: (2022)

Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances
por: Sanfilippo, Cristina, et al.
Publicado: (2023)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
por: Ashton, Nicholas J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ujsm0gk0nmhctrcl63opgpve9h